ZNO fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Zoono Group Ltd. is a pharmaceutical and biotechnology company. It involves in the development, manufacture, and sale of antimicrobial technology effective against all pathogens including bacteria, viruses, mould, algae, and fungi. Its products include aerosol-based sprays, surface sanitizers, treatment of acne, and mould remediation. The company was founded on October 8, 1986 and is headquartered in Auckland, New Zealand.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
ZNO has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company